Table of Contents  

Diagnosis and systemic therapy for hepatobiliary cancer

Steffen Zopf
Published in : HAMDAN MEDICAL JOURNAL ; Vol 10, No 2 (2017)
DOI : 10.7707/hmj.743

Abstract


Cancer of the liver, including hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC), is the second most common cause of cancer-related death, and its incidence rate is increasing. Clinical diagnosis is made by imaging methods based on contrast-enhanced techniques; some special types that include mixed differentiation may be picked up on biopsy. Advanced tumour stages are treated with systemic therapy. In HCC, therapy with the multikinase inhibitor sorafenib is established and new second-line therapies are expected. In CC, however, gemcitabine and cisplatin is standard in first-line therapy. This review highlights the diagnostic possibilities and current developments in the systemic therapy of HCC and CC.

 


View article in  :   PDF     HTML    

Comments on this article



View all comments  |  Add comment 





Home  Editorial Board  Search  Current Issue  Archive Issues  Announcements  Aims & Scope  About the Journal  How to Submit  Contact Us
Find out how to become a part of the HMJ  |   CLICK HERE >>
© Copyright 2012 - 2013 HMJ - HAMDAN Medical Journal. All Rights Reserved         Website Developed By Cedar Solutions INDIA